Finance

Beta
Lists
6541:TPE
Tanvex Biopharma Inc
41,75 TWD
-0,36%
(-0,15) 1D
8-июн., 13:30:01 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
41,80 TWD
High
43,00 TWD
Low
40,70 TWD
Mkt. cap
11,06 млд
Avg. vol.
437,85 миң
Volume
561,94 миң
52-wk high
68,00 TWD
52-wk low
37,30 TWD
EPS
-5,56 TWD
Shares outstanding
242,67 млн
No. of employees
215
Open
41,80 TWD
High
43,00 TWD
Low
40,70 TWD
Mkt. cap
11,06 млд
Avg. vol.
437,85 миң
Volume
561,94 миң
52-wk high
68,00 TWD
52-wk low
37,30 TWD
EPS
-5,56 TWD
Shares outstanding
242,67 млн
No. of employees
215
News stories
From sources across the web
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
Sector-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
46,82 млн
125,34 млн
178,95 млн
132,83 млн
Cost of goods sold
59,47 млн
287,65 млн
422,66 млн
399,36 млн
Cost of revenue
59,47 млн
287,65 млн
422,66 млн
399,36 млн
Research and development expenses
214,73 млн
19,27 млн
13,26 млн
24,24 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110,62 млн
104,56 млн
104,26 млн
108,51 млн
Operating expense
307,11 млн
123,98 млн
129,86 млн
133,70 млн
Total operating expenses
366,58 млн
411,63 млн
552,52 млн
533,06 млн
Operating income
-319,76 млн
-286,29 млн
-373,57 млн
-400,23 млн
Other non operating income
52,71 млн
-372,00 миң
44,99 млн
188,00 миң
EBT including unusual items
-340,38 млн
-273,50 млн
-420,53 млн
-388,70 млн
EBT excluding unusual items
-340,15 млн
-294,27 млн
-305,62 млн
-388,70 млн
Income tax expense
-
-
3,00 миң
27,00 миң
Effective tax rate
-
-
-
-0,01%
Other operating expenses
-
-
-
-
Net income
-340,38 млн
-273,50 млн
-420,54 млн
-388,72 млн
Net profit margin
-727,01%
-218,21%
-235,00%
-292,65%
Earnings per share
-
-
-
-
Interest and investment income
15,11 млн
7,83 млн
11,66 млн
6,03 млн
Interest expense
-11,86 млн
-11,41 млн
-11,31 млн
-11,70 млн
Net interest expenses
3,25 млн
-3,58 млн
354,00 миң
-5,67 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-271,23 млн
-243,08 млн
-370,64 млн
-357,68 млн
Gain or loss from assets sale
226,00 миң
-21,83 млн
62,12 млн
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer